Table of Content

1 Report Overview
1.1 Islet Amyloid Polypeptide Definition
1.2 Market by Type
1.2.1 Global Islet Amyloid Polypeptide Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AC-253
1.2.3 DACRA-042
1.2.4 DACRA-089
1.2.5 KBP-056
1.2.6 KBP-088
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Islet Amyloid Polypeptide Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Metabolic Disorders
1.3.3 Gastrointestinal
1.3.4 Musculoskeletal Disorders
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Islet Amyloid Polypeptide Sales
2.1 Global Islet Amyloid Polypeptide Revenue Estimates and Forecasts 2018-2034
2.2 Global Islet Amyloid Polypeptide Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Islet Amyloid Polypeptide Revenue by Region
2.3.1 Global Islet Amyloid Polypeptide Revenue by Region (2018-2023)
2.3.2 Global Islet Amyloid Polypeptide Revenue by Region (2024-2034)
2.4 Global Islet Amyloid Polypeptide Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Islet Amyloid Polypeptide Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Islet Amyloid Polypeptide Sales Quantity by Region
2.6.1 Global Islet Amyloid Polypeptide Sales Quantity by Region (2018-2023)
2.6.2 Global Islet Amyloid Polypeptide Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Islet Amyloid Polypeptide Sales Quantity by Manufacturers
3.1.1 Global Islet Amyloid Polypeptide Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Islet Amyloid Polypeptide Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Islet Amyloid Polypeptide Sales in 2024
3.2 Global Islet Amyloid Polypeptide Revenue by Manufacturers
3.2.1 Global Islet Amyloid Polypeptide Revenue by Manufacturers (2018-2023)
3.2.2 Global Islet Amyloid Polypeptide Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Islet Amyloid Polypeptide Revenue in 2024
3.3 Global Islet Amyloid Polypeptide Sales Price by Manufacturers
3.4 Global Key Players of Islet Amyloid Polypeptide, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Islet Amyloid Polypeptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Islet Amyloid Polypeptide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Islet Amyloid Polypeptide, Product Offered and Application
3.8 Global Key Manufacturers of Islet Amyloid Polypeptide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Islet Amyloid Polypeptide Sales Quantity by Type
4.1.1 Global Islet Amyloid Polypeptide Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Islet Amyloid Polypeptide Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
4.2 Global Islet Amyloid Polypeptide Revenue by Type
4.2.1 Global Islet Amyloid Polypeptide Historical Revenue by Type (2018-2023)
4.2.2 Global Islet Amyloid Polypeptide Forecasted Revenue by Type (2024-2034)
4.2.3 Global Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
4.3 Global Islet Amyloid Polypeptide Price by Type
4.3.1 Global Islet Amyloid Polypeptide Price by Type (2018-2023)
4.3.2 Global Islet Amyloid Polypeptide Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Islet Amyloid Polypeptide Sales Quantity by Application
5.1.1 Global Islet Amyloid Polypeptide Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Islet Amyloid Polypeptide Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
5.2 Global Islet Amyloid Polypeptide Revenue by Application
5.2.1 Global Islet Amyloid Polypeptide Historical Revenue by Application (2018-2023)
5.2.2 Global Islet Amyloid Polypeptide Forecasted Revenue by Application (2024-2034)
5.2.3 Global Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
5.3 Global Islet Amyloid Polypeptide Price by Application
5.3.1 Global Islet Amyloid Polypeptide Price by Application (2018-2023)
5.3.2 Global Islet Amyloid Polypeptide Price Forecast by Application (2024-2034)
6 North America
6.1 North America Islet Amyloid Polypeptide Sales by Company
6.1.1 North America Islet Amyloid Polypeptide Revenue by Company (2018-2023)
6.1.2 North America Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023)
6.2 North America Islet Amyloid Polypeptide Market Size by Type
6.2.1 North America Islet Amyloid Polypeptide Sales Quantity by Type (2018-2034)
6.2.2 North America Islet Amyloid Polypeptide Revenue by Type (2018-2034)
6.3 North America Islet Amyloid Polypeptide Market Size by Application
6.3.1 North America Islet Amyloid Polypeptide Sales Quantity by Application (2018-2034)
6.3.2 North America Islet Amyloid Polypeptide Revenue by Application (2018-2034)
6.4 North America Islet Amyloid Polypeptide Market Size by Country
6.4.1 North America Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Islet Amyloid Polypeptide Revenue by Country (2018-2034)
6.4.3 North America Islet Amyloid Polypeptide Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Islet Amyloid Polypeptide Sales by Company
7.1.1 Europe Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023)
7.1.2 Europe Islet Amyloid Polypeptide Revenue by Company (2018-2023)
7.2 Europe Islet Amyloid Polypeptide Market Size by Type
7.2.1 Europe Islet Amyloid Polypeptide Sales Quantity by Type (2018-2034)
7.2.2 Europe Islet Amyloid Polypeptide Revenue by Type (2018-2034)
7.3 Europe Islet Amyloid Polypeptide Market Size by Application
7.3.1 Europe Islet Amyloid Polypeptide Sales Quantity by Application (2018-2034)
7.3.2 Europe Islet Amyloid Polypeptide Revenue by Application (2018-2034)
7.4 Europe Islet Amyloid Polypeptide Market Size by Country
7.4.1 Europe Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Islet Amyloid Polypeptide Revenue by Country (2018-2034)
7.4.3 Europe Islet Amyloid Polypeptide Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Islet Amyloid Polypeptide Sales by Company
8.1.1 China Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023)
8.1.2 China Islet Amyloid Polypeptide Revenue by Company (2018-2023)
8.2 China Islet Amyloid Polypeptide Market Size by Type
8.2.1 China Islet Amyloid Polypeptide Sales Quantity by Type (2018-2034)
8.2.2 China Islet Amyloid Polypeptide Revenue by Type (2018-2034)
8.3 China Islet Amyloid Polypeptide Market Size by Application
8.3.1 China Islet Amyloid Polypeptide Sales Quantity by Application (2018-2034)
8.3.2 China Islet Amyloid Polypeptide Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Islet Amyloid Polypeptide Sales by Company
9.1.1 APAC Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023)
9.1.2 APAC Islet Amyloid Polypeptide Revenue by Company (2018-2023)
9.2 APAC Islet Amyloid Polypeptide Market Size by Type
9.2.1 APAC Islet Amyloid Polypeptide Sales Quantity by Type (2018-2034)
9.2.2 APAC Islet Amyloid Polypeptide Revenue by Type (2018-2034)
9.3 APAC Islet Amyloid Polypeptide Market Size by Application
9.3.1 APAC Islet Amyloid Polypeptide Sales Quantity by Application (2018-2034)
9.3.2 APAC Islet Amyloid Polypeptide Revenue by Application (2018-2034)
9.4 APAC Islet Amyloid Polypeptide Market Size by Region
9.4.1 APAC Islet Amyloid Polypeptide Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Islet Amyloid Polypeptide Revenue by Region (2018-2034)
9.4.3 APAC Islet Amyloid Polypeptide Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales by Company
10.1.1 Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Islet Amyloid Polypeptide Market Size by Type
10.2.1 Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Islet Amyloid Polypeptide Market Size by Application
10.3.1 Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Islet Amyloid Polypeptide Market Size by Country
10.4.1 Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Adocia SAS
11.1.1 Adocia SAS Company Information
11.1.2 Adocia SAS Overview
11.1.3 Adocia SAS Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Adocia SAS Islet Amyloid Polypeptide Products and Services
11.1.5 Adocia SAS Islet Amyloid Polypeptide SWOT Analysis
11.1.6 Adocia SAS Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Information
11.2.2 AstraZeneca Plc Overview
11.2.3 AstraZeneca Plc Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 AstraZeneca Plc Islet Amyloid Polypeptide Products and Services
11.2.5 AstraZeneca Plc Islet Amyloid Polypeptide SWOT Analysis
11.2.6 AstraZeneca Plc Recent Developments
11.3 Eli Lilly and Co
11.3.1 Eli Lilly and Co Company Information
11.3.2 Eli Lilly and Co Overview
11.3.3 Eli Lilly and Co Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Eli Lilly and Co Islet Amyloid Polypeptide Products and Services
11.3.5 Eli Lilly and Co Islet Amyloid Polypeptide SWOT Analysis
11.3.6 Eli Lilly and Co Recent Developments
11.4 Neurimmune Holding AG
11.4.1 Neurimmune Holding AG Company Information
11.4.2 Neurimmune Holding AG Overview
11.4.3 Neurimmune Holding AG Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Neurimmune Holding AG Islet Amyloid Polypeptide Products and Services
11.4.5 Neurimmune Holding AG Islet Amyloid Polypeptide SWOT Analysis
11.4.6 Neurimmune Holding AG Recent Developments
11.5 Nordic Bioscience A/S
11.5.1 Nordic Bioscience A/S Company Information
11.5.2 Nordic Bioscience A/S Overview
11.5.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Products and Services
11.5.5 Nordic Bioscience A/S Islet Amyloid Polypeptide SWOT Analysis
11.5.6 Nordic Bioscience A/S Recent Developments
11.6 Prothena Corp Plc
11.6.1 Prothena Corp Plc Company Information
11.6.2 Prothena Corp Plc Overview
11.6.3 Prothena Corp Plc Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Prothena Corp Plc Islet Amyloid Polypeptide Products and Services
11.6.5 Prothena Corp Plc Islet Amyloid Polypeptide SWOT Analysis
11.6.6 Prothena Corp Plc Recent Developments
11.7 reMYND NV
11.7.1 reMYND NV Company Information
11.7.2 reMYND NV Overview
11.7.3 reMYND NV Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 reMYND NV Islet Amyloid Polypeptide Products and Services
11.7.5 reMYND NV Islet Amyloid Polypeptide SWOT Analysis
11.7.6 reMYND NV Recent Developments
11.8 Zealand Pharma AS
11.8.1 Zealand Pharma AS Company Information
11.8.2 Zealand Pharma AS Overview
11.8.3 Zealand Pharma AS Islet Amyloid Polypeptide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Zealand Pharma AS Islet Amyloid Polypeptide Products and Services
11.8.5 Zealand Pharma AS Islet Amyloid Polypeptide SWOT Analysis
11.8.6 Zealand Pharma AS Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Islet Amyloid Polypeptide Value Chain Analysis
12.2 Islet Amyloid Polypeptide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Islet Amyloid Polypeptide Production Mode & Process
12.4 Islet Amyloid Polypeptide Sales and Marketing
12.4.1 Islet Amyloid Polypeptide Sales Channels
12.4.2 Islet Amyloid Polypeptide Distributors
12.5 Islet Amyloid Polypeptide Customers
13 Market Dynamics
13.1 Islet Amyloid Polypeptide Industry Trends
13.2 Islet Amyloid Polypeptide Market Drivers
13.3 Islet Amyloid Polypeptide Market Challenges
13.4 Islet Amyloid Polypeptide Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AC-253
Table 3. Major Manufacturers of DACRA-042
Table 4. Major Manufacturers of DACRA-089
Table 5. Major Manufacturers of KBP-056
Table 6. Major Manufacturers of KBP-088
Table 7. Major Manufacturers of Others
Table 8. Global Islet Amyloid Polypeptide Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Islet Amyloid Polypeptide Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Islet Amyloid Polypeptide Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2018-2023)
Table 12. Global Islet Amyloid Polypeptide Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2024-2034)
Table 14. Global Islet Amyloid Polypeptide Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 15. Global Islet Amyloid Polypeptide Sales by Region (2018-2023) & (K Pcs)
Table 16. Global Islet Amyloid Polypeptide Sales Market Share by Region (2018-2023)
Table 17. Global Islet Amyloid Polypeptide Sales by Region (2024-2034) & (K Pcs)
Table 18. Global Islet Amyloid Polypeptide Sales Market Share by Region (2024-2034)
Table 19. Global Islet Amyloid Polypeptide Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 20. Global Islet Amyloid Polypeptide Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global Islet Amyloid Polypeptide Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Islet Amyloid Polypeptide Revenue Share by Manufacturers (2018-2023)
Table 23. Global Islet Amyloid Polypeptide Price by Manufacturers 2018-2023 (USD/Pcs)
Table 24. Global Key Players of Islet Amyloid Polypeptide, Industry Ranking, 2021 VS 2024
Table 25. Global Islet Amyloid Polypeptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Islet Amyloid Polypeptide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Islet Amyloid Polypeptide as of 2024)
Table 27. Global Key Manufacturers of Islet Amyloid Polypeptide, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Islet Amyloid Polypeptide, Product Offered and Application
Table 29. Global Key Manufacturers of Islet Amyloid Polypeptide, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 32. Global Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 33. Global Islet Amyloid Polypeptide Sales Quantity Share by Type (2018-2023)
Table 34. Global Islet Amyloid Polypeptide Sales Quantity Share by Type (2024-2034)
Table 35. Global Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Islet Amyloid Polypeptide Revenue Share by Type (2018-2023)
Table 38. Global Islet Amyloid Polypeptide Revenue Share by Type (2024-2034)
Table 39. Islet Amyloid Polypeptide Price by Type (2018-2023) & (USD/Pcs)
Table 40. Global Islet Amyloid Polypeptide Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 41. Global Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 42. Global Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 43. Global Islet Amyloid Polypeptide Sales Quantity Share by Application (2018-2023)
Table 44. Global Islet Amyloid Polypeptide Sales Quantity Share by Application (2024-2034)
Table 45. Global Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Islet Amyloid Polypeptide Revenue Share by Application (2018-2023)
Table 48. Global Islet Amyloid Polypeptide Revenue Share by Application (2024-2034)
Table 49. Islet Amyloid Polypeptide Price by Application (2018-2023) & (USD/Pcs)
Table 50. Global Islet Amyloid Polypeptide Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 51. North America Islet Amyloid Polypeptide Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023) & (K Pcs)
Table 53. North America Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 54. North America Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 55. North America Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 58. North America Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 59. North America Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America Islet Amyloid Polypeptide Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America Islet Amyloid Polypeptide Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Islet Amyloid Polypeptide Sales Quantity by Country (2018-2023) & (K Pcs)
Table 65. North America Islet Amyloid Polypeptide Sales Quantity by Country (2024-2034) & (K Pcs)
Table 66. Europe Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023) & (K Pcs)
Table 67. Europe Islet Amyloid Polypeptide Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 69. Europe Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 70. Europe Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 73. Europe Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 74. Europe Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe Islet Amyloid Polypeptide Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Islet Amyloid Polypeptide Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Islet Amyloid Polypeptide Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. Europe Islet Amyloid Polypeptide Sales Quantity by Country (2024-2034) & (K Pcs)
Table 81. China Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023) & (K Pcs)
Table 82. China Islet Amyloid Polypeptide Revenue by Company (2018-2023) & (US$ Million)
Table 83. China Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. China Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 85. China Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 86. China Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 88. China Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 89. China Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 90. China Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023) & (K Pcs)
Table 92. APAC Islet Amyloid Polypeptide Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 94. APAC Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 95. APAC Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 98. APAC Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 99. APAC Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Islet Amyloid Polypeptide Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC Islet Amyloid Polypeptide Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC Islet Amyloid Polypeptide Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Islet Amyloid Polypeptide Sales Quantity by Region (2018-2023) & (K Pcs)
Table 105. APAC Islet Amyloid Polypeptide Sales Quantity by Region (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Company (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Type (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Application (2018-2023) & (K Pcs)
Table 113. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Application (2024-2034) & (K Pcs)
Table 114. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Country (2018-2023) & (K Pcs)
Table 120. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity by Country (2024-2034) & (K Pcs)
Table 121. Adocia SAS Company Information
Table 122. Adocia SAS Description and Overview
Table 123. Adocia SAS Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 124. Adocia SAS Islet Amyloid Polypeptide Product and Services
Table 125. Adocia SAS Islet Amyloid Polypeptide SWOT Analysis
Table 126. Adocia SAS Recent Developments
Table 127. AstraZeneca Plc Company Information
Table 128. AstraZeneca Plc Description and Overview
Table 129. AstraZeneca Plc Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 130. AstraZeneca Plc Islet Amyloid Polypeptide Product and Services
Table 131. AstraZeneca Plc Islet Amyloid Polypeptide SWOT Analysis
Table 132. AstraZeneca Plc Recent Developments
Table 133. Eli Lilly and Co Company Information
Table 134. Eli Lilly and Co Description and Overview
Table 135. Eli Lilly and Co Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 136. Eli Lilly and Co Islet Amyloid Polypeptide Product and Services
Table 137. Eli Lilly and Co Islet Amyloid Polypeptide SWOT Analysis
Table 138. Eli Lilly and Co Recent Developments
Table 139. Neurimmune Holding AG Company Information
Table 140. Neurimmune Holding AG Description and Overview
Table 141. Neurimmune Holding AG Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Neurimmune Holding AG Islet Amyloid Polypeptide Product and Services
Table 143. Neurimmune Holding AG Islet Amyloid Polypeptide SWOT Analysis
Table 144. Neurimmune Holding AG Recent Developments
Table 145. Nordic Bioscience A/S Company Information
Table 146. Nordic Bioscience A/S Description and Overview
Table 147. Nordic Bioscience A/S Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Nordic Bioscience A/S Islet Amyloid Polypeptide Product and Services
Table 149. Nordic Bioscience A/S Islet Amyloid Polypeptide SWOT Analysis
Table 150. Nordic Bioscience A/S Recent Developments
Table 151. Prothena Corp Plc Company Information
Table 152. Prothena Corp Plc Description and Overview
Table 153. Prothena Corp Plc Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 154. Prothena Corp Plc Islet Amyloid Polypeptide Product and Services
Table 155. Prothena Corp Plc Islet Amyloid Polypeptide SWOT Analysis
Table 156. Prothena Corp Plc Recent Developments
Table 157. reMYND NV Company Information
Table 158. reMYND NV Description and Overview
Table 159. reMYND NV Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 160. reMYND NV Islet Amyloid Polypeptide Product and Services
Table 161. reMYND NV Islet Amyloid Polypeptide SWOT Analysis
Table 162. reMYND NV Recent Developments
Table 163. Zealand Pharma AS Company Information
Table 164. Zealand Pharma AS Description and Overview
Table 165. Zealand Pharma AS Islet Amyloid Polypeptide Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 166. Zealand Pharma AS Islet Amyloid Polypeptide Product and Services
Table 167. Zealand Pharma AS Islet Amyloid Polypeptide SWOT Analysis
Table 168. Zealand Pharma AS Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Islet Amyloid Polypeptide Distributors List
Table 172. Islet Amyloid Polypeptide Customers List
Table 173. Islet Amyloid Polypeptide Market Trends
Table 174. Islet Amyloid Polypeptide Market Drivers
Table 175. Islet Amyloid Polypeptide Market Challenges
Table 176. Islet Amyloid Polypeptide Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Islet Amyloid Polypeptide Product Picture
Figure 2. Global Islet Amyloid Polypeptide Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Islet Amyloid Polypeptide Market Share by Type in 2024 & 2034
Figure 4. AC-253 Product Picture
Figure 5. DACRA-042 Product Picture
Figure 6. DACRA-089 Product Picture
Figure 7. KBP-056 Product Picture
Figure 8. KBP-088 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Islet Amyloid Polypeptide Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Islet Amyloid Polypeptide Market Share by Application in 2024 & 2034
Figure 12. Metabolic Disorders
Figure 13. Gastrointestinal
Figure 14. Musculoskeletal Disorders
Figure 15. Others
Figure 16. Islet Amyloid Polypeptide Report Years Considered
Figure 17. Global Islet Amyloid Polypeptide Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Islet Amyloid Polypeptide Revenue 2018-2034 (US$ Million)
Figure 19. Global Islet Amyloid Polypeptide Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 20. Global Islet Amyloid Polypeptide Sales Quantity 2018-2034 (K Pcs)
Figure 21. Global Islet Amyloid Polypeptide Sales Quantity Market Share by Region (2018-2023)
Figure 22. Global Islet Amyloid Polypeptide Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Islet Amyloid Polypeptide Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. North America Islet Amyloid Polypeptide Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Islet Amyloid Polypeptide Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. Europe Islet Amyloid Polypeptide Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Islet Amyloid Polypeptide Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. China Islet Amyloid Polypeptide Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Islet Amyloid Polypeptide Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. APAC Islet Amyloid Polypeptide Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 32. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Islet Amyloid Polypeptide Sales Quantity in 2024
Figure 34. The Top 10 and Top 5 Players Market Share by Islet Amyloid Polypeptide Revenue in 2024
Figure 35. Islet Amyloid Polypeptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Global Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 38. Global Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 40. North America Islet Amyloid Polypeptide Revenue Market Share by Company in 2024
Figure 41. North America Islet Amyloid Polypeptide Sales Quantity Market Share by Company in 2024
Figure 42. North America Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 44. North America Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 46. North America Islet Amyloid Polypeptide Revenue Share by Country (2018-2034)
Figure 47. North America Islet Amyloid Polypeptide Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Islet Amyloid Polypeptide Sales Quantity Market Share by Company in 2024
Figure 51. Europe Islet Amyloid Polypeptide Revenue Market Share by Company in 2024
Figure 52. Europe Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 54. Europe Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 56. Europe Islet Amyloid Polypeptide Revenue Share by Country (2018-2034)
Figure 57. Europe Islet Amyloid Polypeptide Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 59. France Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 63. China Islet Amyloid Polypeptide Sales Quantity Market Share by Company in 2024
Figure 64. China Islet Amyloid Polypeptide Revenue Market Share by Company in 2024
Figure 65. China Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 67. China Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 69. APAC Islet Amyloid Polypeptide Sales Quantity Market Share by Company in 2024
Figure 70. APAC Islet Amyloid Polypeptide Revenue Market Share by Company in 2024
Figure 71. APAC Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 73. APAC Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 75. APAC Islet Amyloid Polypeptide Revenue Share by Region (2018-2034)
Figure 76. APAC Islet Amyloid Polypeptide Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 81. India Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Islet Amyloid Polypeptide Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Islet Amyloid Polypeptide Revenue Share by Country (2018-2034)
Figure 90. Brazil Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Islet Amyloid Polypeptide Revenue (2018-2034) & (US$ Million)
Figure 95. Islet Amyloid Polypeptide Value Chain
Figure 96. Islet Amyloid Polypeptide Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed